The FOURDth Dimension is the unique dimension that connects, contextualizes, and transforms the others. It is the missing link that makes the whole greater than the sum of its parts, revealing the relationships, interactions, trajectories, meaning, and possibilities that might otherwise remain hidden.
The FOURDth Dimension transforms what is known into what becomes possible.
The FOURDth Principle is the discipline of seeking the next dimension—the third, fourth, fifth, or nth—that connects the others in ways that change how we see, understand, and act. The number is not the point; the pursuit is: continually looking beyond what is known, visible, or conventionally understood to discover what is missing.
The FOURDth Principle puts this pursuit into practice:
Seek the next dimension.
Connect what appears separate.
Discover what emerges when the whole comes together.
It means looking beyond isolated problems, disciplines, data points, and moments in time to uncover the context, relationships, trajectories, and possibilities that conventional perspectives may overlook.
The goal is not simply to see more, know more, or add more.
It is to find the missing dimension that changes the picture—and unlocks what was previously out of reach.
FOURD is about seeing health differently—and seeing more of it.
The name FOURD reflects the application of the FOURDth dimension: a broader perspective that connects, contextualizes, and transforms the others, revealing a more complete understanding of health and opening new possibilities.
Our name embodies the very principle behind it: the FOURDth dimension. As our understanding of health evolves, so does the meaning of FOURD—embracing new dimensions, perspectives, and ways of seeing and making the whole more whole.
FOURD is not confined to a fixed definition. Its meaning grows with discovery, deepens with understanding, and expands with possibility.
The FOURDth idea takes different forms across our work:
FOURD is building a broader, interconnected platform for Total Health—so broader health can compound into fuller lives and expanded possibilities for everyone.
We begin with health itself—and end with health outcomes. Between them, we connect what it takes to understand, pursue, and protect health: science, technology, data, insights, understanding, behavior, and systems.
FOURD is not confined to health -care, -technology, -insurance, -data, -AI, -longevity, -wellness, or other means through which health is pursued.
FOURD works across two connected fronts: helping innovators and institutions advance health today while building consumer-centered platforms for how individuals can understand, pursue, protect, and own their Total Health over time.
FOURDProducts
We build consumer-powered, interoperable platforms and products that reconnect individuals with their longitudinal health data and context—making health more visible, intelligence more useful, and decisions more informed.
These platforms are designed around individual agency, privacy, and principled data use: Data for you, not from you.
FOURDServices
We advise biopharma, biotech, medtech, and other health innovators through strategy, operational leadership, delivery, and governance.
We help organizations interpret scientific, technological, market, and human shifts; translate them into meaningful opportunities; and move complex health programs toward real-world outcomes.
Together, these two fronts connect what health innovation can create with what people can understand, use, and own.
Vision
Mission
Our values set the direction. Our behaviors are how we follow it.Together, they form the human code behind FOURD—guiding how we think, decide, collaborate, build, and serve.
Challenge convention. Create the next path.
We pursue novel approaches and disruptive paradigms with conviction. Leadership means questioning inherited answers, seeing possibilities others may overlook, and having the courage to move meaningful ideas forward.
Boldness is not change for its own sake. It is the willingness to rethink what limits progress—and build what should come next.
Effort matters. Impact completes it.
We respect every process and journey, but measure success by what they ultimately change.
We take accountability for our decisions, actions, and results—from the quality of our thinking to the real-world impact of what we build.
Progress is not simply work completed.
It is value created and outcomes advanced.
Listen deeply. Act with purpose.
Service is not passive. It requires humility to understand what others need, judgment to know what matters, and strength to act with speed and precision.
We serve people, colleagues, innovators, enterprises, and institutions across geographies and health contexts—bringing empathy without losing rigor, and responsiveness without compromising quality.
Strength becomes more meaningful when it is used in service of others.
Earn it differently. Prove it continuously.
Trust is too important to be reduced to promises, policies, or statements of intent.
FOURD seeks to disrupt how trust is earned—through independence, transparency, data integrity, consistency, and actions that can withstand scrutiny.
We aim to make trust visible in how information is handled, how decisions are made, how interests are balanced, and how commitments are kept.
In an increasingly noisy and fragmented health ecosystem, we aspire to create neutral ground where people and organizations can have confidence not because they were asked to trust us—
but because we continually give them reason to.
Make Health visible, actionable, and ownable.
People are more than patients, subjects, users, or sources of data.
We design for their agency—to understand Health, make informed decisions, participate in creating value, and choose how their data is used, shared, or monetized.
Putting YOU in charge also changes how FOURD approaches problems: from business-first or system-first toward human-first—asking what science, technology, products, and institutions can do better for the people they ultimately exist to serve.
And “YOU” is intentionally inclusive.
Our ambition is to extend that agency to more people, across more geographies, backgrounds, and health contexts—so advances in Health can be shaped by and benefit more of humanity.
Health is personal. Its agency should be too.
Founder-CEO
Product · Platform · Total Health
Repeat founder and healthcare technology executive with 25 years of experience building at the intersection of healthcare, technology, and business. Has founded two companies, including one successfully exited venture, and has built new ventures, platforms, teams, and organizations across startup, growth-stage, and global enterprise environments.
Brings a distinctive combination of healthcare domain expertise, technology fluency, and hands-on company-building experience. His work spans product and platform strategy, data and AI, digital transformation, operations, commercialization, organizational scale-up, and capital allocation. He has spent his career identifying high-value problems, translating emerging technologies into practical solutions, assembling strong teams, and building the capabilities required to move from idea to execution and scale.
As a founder, operator, and advisor, he has worked with leadership teams on growth, innovation, investment, and transformation, with a consistent focus on using technology and data to improve how healthcare organizations make decisions, operate, and create value.
Holds an MBA from The Wharton School, University of Pennsylvania, where he was a Palmer Scholar; an M.S. in Chemical Engineering from the University of Pittsburgh; and a B.S. in Chemical Engineering from the Indian Institute of Technology, Bombay.
Strategic Advisor & Operational Leader
Strategy · Portfolio · Enterprise execution
Biopharma executive and advisor with 25 years of experience across drug development, CMC/Technical Development, Technical Operations, portfolio strategy, and enterprise transformation. Brings deep technical expertise together with strategic breadth across the full biopharma value chain—from product and platform strategy through development, manufacturing, supply, quality, commercialization, and lifecycle management.
Strategic, Technical Advisor
CMC · MSAT · Process Sciences · Quality
Siddhartha (Sid) Jain is a biopharmaceutical leader with nearly two decades of experience in CMC development, MSAT, Process Sciences and Quality roles. Sid has contributed to the CMC development and manufacturing of several commercial biologics drugs (including Orencia, Eylea, Praluent and Dupixent) and clinical molecules (including one of the first AI-designed monoclonal antibodies).
Strategic, Technical Advisor
Technical Operations · CMC Strategy · Process Development · Manufacturing
Mani Sundararajan, Ph.D., is a biopharmaceutical executive with extensive experience in technical operations, CMC strategy, process development and drug development across the pharmaceutical and biotechnology industries. He has held senior leadership roles at organizations including Fulcrum Therapeutics, Seagen, Takeda, Shire, AstraZeneca, Bristol Myers Squibb and DuPont Pharmaceuticals, contributing to pharmaceutical development, manufacturing strategy and technical operations across complex development and supply networks.
RWD/RWE · Digital measures · Governed AI
Shapes data architecture, digital operating models and governed AI applications that improve decisions and strengthen regulated workflows.
Clinical strategy · Trial execution · Evidence
Advises on clinical program strategy, trial design and execution, and evidence generation across biopharma and diagnostics portfolios.
Quality systems · CMC regulatory · Compliance
Strengthens quality systems, remediation, and regulatory CMC pathways so programs stay inspection-ready across the product lifecycle.
Operating model · Change · Benefit realization
Designs operating models and transformation programs that embed lasting capability—so outcomes are delivered and sustained with client teams.
FOURD is building deliberately. If this health ambition feels like work you should be part of, tell us what you want to build—across HealthTech and CompuTech.
FOURD is seeking investors for our products—consumer health intelligence still taking shape, built at the intersection of HealthTech and CompuTech. If you back category-defining companies before they are obvious, this is the window.
Early partners help set the pace: capital, counsel, and conviction while the products are still being built. We’re looking for investors who want ownership in what comes next—not a seat after the market has already priced the story.